08.07.2022 / Statement
Families USA’s Isasi: Stopping Big Pharma’s price gouging and lowering the cost of prescription drugs is a huge victory for families across this nation
WASHINGTON, D.C. – Families USA Executive Director Frederick Isasi released the following statement today after the Senate passed a reconciliation bill allowing Medicare to negotiate costly prescription drugs, extending tax credits to help people afford health insurance purchased through the marketplaces, and investing in renewable energy and corporate tax reform:
“David may just triumph over Goliath. Stopping Big Pharma’s price gouging and lowering the cost of prescription drugs is a huge victory for families across this nation. Senators passed a strong and wildly popular bill that will take on the drug industry’s pricing abuses and curb health insurance premium spikes at a time when working families need it the most.
“We remain committed to pursuing other opportunities to address the critical issues that are absent from the Senate deal. In particular, we must ensure that our most vulnerable families living in states that have refused to extend Medicaid have coverage that protects their health and financial security. We must also finish the work to ensure people who are covered under Medicare can have their oral health needs met and moms and new babies have access to post-partum health care, key policies that were part of earlier versions of this legislation.
“This has been a hard-fought effort over years and years against one of the country’s most powerful corporate lobbies. We are now closer than we’ve ever been to ending Big Pharma’s price gouging on the medicine and treatments so many of us depend on. Over 80 percent of Americans – including Republicans, Democrats and independents – want the reforms Congress is on the verge of passing. In today’s highly partisan political landscape, it is hard to find any policy this popular. Lowering absurdly high drug prices and supporting their constituents should be a no-brainer for every member of Congress.”